SCHEMBL13626412

SCHEMBL13626412

CCCC(O)c1ccc(S)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
RIPK1 Q13546 1/20 0.38
PDE4A P27815 2/20 0.36
PDE4B Q07343 2/20 0.36
PDE4C Q08493 2/20 0.36
PDE4D Q08499 2/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
TAAR1 Q96RJ0 3/20 0.35
KDM4E B2RXH2 3/20 0.35
HIF1A Q16665 2/20 0.35
ALDH1A1 P00352 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
HTR1A P08908 1/20 0.35
THPO P40225 1/20 0.35
BLM P54132 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NMUR2 Q9GZQ4 1/20 0.35
CYP2C9 P11712 1/20 0.35
AOC3 Q16853 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21633858 0.89 LMNA (0.48) LMNARIPK1PDE4APDE4BPDE4C
SCHEMBL29861491 0.82 LMNA (0.43) LMNARIPK1PDE4APDE4BPDE4C
SCHEMBL1917704 0.80 TAAR1 (0.56) LMNAESR1ESR2TAAR1KDM4E
SCHEMBL540784 0.80 ALDH1A1 (0.42) LMNARIPK1PDE4APDE4BPDE4C
SCHEMBL6055300 0.80 LMNA (0.41) LMNARIPK1PDE4APDE4BPDE4C
SCHEMBL18905454 0.80 LMNA (0.41) LMNARIPK1PDE4APDE4BPDE4C
SCHEMBL9772644 0.78 AOC3 (0.53) LMNAHTR1ASMN1; SMN2AOC3
SCHEMBL2678379 0.78 CYP19A1 (0.42) LMNARIPK1PDE4APDE4BPDE4C
SCHEMBL6111588 0.78 KMT2A (0.41) LMNAKMT2A
SCHEMBL906150 0.78 AOC3 (0.53) KDM4EALDH1A1HTR1ACYP2C9AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009142967-A1 THERAPEUTIC PROSTAGLANDIN COMPOUNDS USED AS OCULAR HYPOTENSIVE AGENTS ALLERGAN, INC. (US) 2009-11-26 WO disclosed